Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 7, Issue 11
June 13 2023
Issue Cover

Table of Contents

INSIDE BLOOD ADVANCES

On a collision course: SARS-CoV-2 variants and CAR T cells
Clinical Trials & Observations
Jeffery J. Auletta
View Articletitled, On a collision course: SARS-CoV-2 variants and CAR T cells

STIMULUS REPORT

Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
Clinical Trials & Observations
Ulrich Jaeger,Nina Worel,Joseph P. McGuirk,Peter A. Riedell,Isabelle Fleury,Yan Du,Xia Han,David Pearson,Santiago Redondo,Edmund K. Waller
View Articletitled, Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
Supplemental data

REVIEW ARTICLE

The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
Wael Gamal,Eva Sahakian,Javier Pinilla-Ibarz
View Articletitled, The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?

CLINICAL TRIALS AND OBSERVATIONS

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
Clinical Trials & Observations
Narendranath Epperla,Jeffrey Switchenko,Veronika Bachanova,James N. Gerson,Stefan K. Barta,Max J. Gordon,Alexey V. Danilov,Natalie S. Grover,Stephanie Mathews,Madelyn Burkart,Reem Karmali,Yazeed Sawalha,Brian T. Hill,Nilanjan Ghosh,Steven I. Park,David A. Bond,Mehdi Hamadani,Timothy S. Fenske,Peter Martin,Mary-Kate Malecek,Brad S. Kahl,Christopher R. Flowers,Brian K. Link,Lawrence D. Kaplan,David J. Inwards,Andrew L. Feldman,Eric D. Hsi,Kami Maddocks,Kristie A. Blum,Nancy L. Bartlett,James R. Cerhan,John P. Leonard,Thomas M. Habermann,Matthew J. Maurer,Jonathon B. Cohen
View Articletitled, Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
Supplemental data
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome
Clinical Trials & Observations
Courtney D. DiNardo,Sangeetha Venugopal,Curtis Lachowiez,Koichi Takahashi,Sanam Loghavi,Guillermo Montalban-Bravo,Xuemei Wang,Hetty Carraway,Mikkael Sekeres,Ameenah Sukkur,Danielle Hammond,Kelly Chien,Abhishek Maiti,Lucia Masarova,Koji Sasaki,Yesid Alvarado,Tapan Kadia,Nicholas J. Short,Naval Daver,Gautam Borthakur,Farhad Ravandi,Hagop M. Kantarjian,Bhumika Patel,Amy Dezern,Gail Roboz,Guillermo Garcia-Manero
View Articletitled, Targeted therapy with the mutant <em>IDH2</em> inhibitor enasidenib for high-risk <em>IDH2</em>-mutant myelodysplastic syndrome
Supplemental data
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany
Clinical Trials & Observations
Peter Bader,Claudia Rossig,Martin Hutter,Francis Ayuketang Ayuk,Claudia D. Baldus,Veit L. Bücklein,Halvard Bonig,Gunnar Cario,Hermann Einsele,Udo Holtick,Christian Koenecke,Shahrzad Bakhtiar,Annette Künkele,Roland Meisel,Fabian Müller,Ingo Müller,Olaf Penack,Eva Rettinger,Martin G. Sauer,Paul-Gerhardt Schlegel,Jan Soerensen,Arend von Stackelberg,Brigitte Strahm,Julia Hauer,Tobias Feuchtinger,Andrea Jarisch
View Articletitled, CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany
Supplemental data
Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
Clinical Trials & Observations
Ryan C. Lynch,Christina Poh,Chaitra S. Ujjani,Edus H. Warren, III,Stephen D. Smith,Mazyar Shadman,Karolyn Morris,Sydney Lee,Heather Rasmussen,Susan Ottemiller,Megan Shelby,Sarith Keo,Kaitlin Verni,David M. Kurtz,Ash A. Alizadeh,Jacob J. Chabon,Gregory J. Hogan,Andre Schulz,Ted Gooley,Jenna M. Voutsinas,Ajay K. Gopal
View Articletitled, Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
Supplemental data
Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria
Clinical Trials & Observations
Raymond Siu Ming Wong,Juan Ramon Navarro-Cabrera,Narcisa Sonia Comia,Yeow Tee Goh,Henry Idrobo,Daolada Kongkabpan,David Gómez-Almaguer,Mohammed Al-Adhami,Temitayo Ajayi,Paulo Alvarenga,Jessica Savage,Pascal Deschatelets,Cedric Francois,Federico Grossi,Teresita Dumagay
View Articletitled, Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria
Supplemental data
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
Clinical Trials & Observations
Danielle S. Wallace,Clive S. Zent,Andrea M. Baran,Patrick M. Reagan,Carla Casulo,Geoffrey Rice,Jonathan W. Friedberg,Paul M. Barr
View Articletitled, Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
Supplemental data
Comparison of the effectiveness and safety of direct oral anticoagulants: a nationwide propensity score–weighted study
Clinical Trials & Observations
Arnar B. Ingason,Johann P. Hreinsson,Arnar S. Agustsson,Sigrun H. Lund,Edward Rumba,Daniel A. Palsson,Indridi E. Reynisson,Brynja R. Gudmundsdottir,Pall T. Onundarson,Einar S. Bjornsson
View Articletitled, Comparison of the effectiveness and safety of direct oral anticoagulants: a nationwide propensity score–weighted study
Supplemental data
A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale
Clinical Trials & Observations
Max J. Gordon,Zhigang Duan,Hui Zhao,Loretta Nastoupil,Alessandra Ferrajoli,Alexey V. Danilov,Sharon H. Giordano
View Articletitled, A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale
Supplemental data
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Clinical Trials & Observations
Jaap A. van Doesum,Jon Salmanton-García,Francesco Marchesi,Roberta Di Blasi,Iker Falces-Romero,Alba Cabirta,Francesca Farina,Caroline Besson,Barbora Weinbergerová,Jens Van Praet,Martin Schönlein,Alberto López-García,Sylvain Lamure,Anna Guidetti,Cristina De Ramón-Sánchez,Josip Batinić,Eleni Gavriilaki,Athanasios Tragiannidis,Maria Chiara Tisi,Gaëtan Plantefeve,Verena Petzer,Irati Ormazabal-Vélez,Joyce Marques de Almeida,Monia Marchetti,Johan Maertens,Marina Machado,Austin Kulasekararaj,José-Ángel Hernández-Rivas,Maria Gomes da Silva,Noemí Fernández,Ildefonso Espigado,Ľuboš Drgoňa,Giulia Dragonetti,Elisabetta Metafuni,Maria Calbacho,Ola Blennow,Dominik Wolf,Bjorn van Anrooij,Raquel Nunes Rodrigues,Anna Nordlander,Juan-Alberto Martín-González,Raphaël Liévin,Moraima Jiménez,Stefanie K. Gräfe,Ramón García-Sanz,Raúl Córdoba,Laman Rahimli,Tom van Meerten,Oliver A. Cornely,Livio Pagano
View Articletitled, Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Supplemental data
On a collision course: SARS-CoV-2 variants and CAR T cells
Clinical Trials & Observations
Jeffery J. Auletta
View Articletitled, On a collision course: SARS-CoV-2 variants and CAR T cells

HEMATOPOIESIS AND STEM CELLS

A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation
Chen Wang,Zhaowei Tu,Xiongwei Cai,Weinan Wang,Ashely K. Davis,Kalpana Nattamai,Aditi Paranjpe,Philip Dexheimer,Jianqiang Wu,Frank Lei Huang,Hartmut Geiger,Gang Huang,Yi Zheng
View Articletitled, A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation
Supplemental data
Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis
Yanan Li,Wei Yang,Helen C. Wang,Riddhi M. Patel,Emily B. Casey,Elisabeth Denby,Jeffrey A. Magee
View Articletitled, Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Dasatinib-induced spleen contraction leads to transient lymphocytosis
Ana Marcos-Jiménez,Daniela Claudino Carvoeiro,Nora Ruef,Carlos Cuesta-Mateos,Emilia Roy-Vallejo,Valle Gómez-García de Soria,Claudio Laganá,Lourdes del Campo,Pablo Zubiaur,Gonzalo Villapalos-García,Francisco Abad-Santos,Jens V. Stein,Cecilia Muñoz-Calleja
View Articletitled, Dasatinib-induced spleen contraction leads to transient lymphocytosis
Supplemental data
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy
Alexandre V. Hirayama,Cassie K. Chou,Takahiro Miyazaki,Rachel N. Steinmetz,Henna A. Di,Simon P. Fraessle,Jordan Gauthier,Salvatore Fiorenza,Reed M. Hawkins,Willem W. Overwijk,Stanley R. Riddell,Mario Q. Marcondes,Cameron J. Turtle
View Articletitled, A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy
Supplemental data

MYELOID NEOPLASIA

Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
Yazad D. Irani,Chung H. Kok,Jade Clarson,Naranie Shanmuganathan,Susan Branford,David T. Yeung,David M. Ross,Timothy P. Hughes,Agnes S. M. Yong
View Articletitled, Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
Supplemental data
Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells
Feng Pan,Masayuki Iwasaki,Wenqi Wu,Yanan Jiang,Xin Yang,Li Zhu,Zhigang Zhao,Michael L. Cleary
View Articletitled, Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells
Supplemental data
SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
Richard J. Marrero,Xueyuan Cao,Huiyun Wu,Abdelrahman H. Elsayed,Jeffery M. Klco,Raul C. Ribeiro,Jeffrey E. Rubnitz,Xiaotu Ma,Soheil Meshinchi,Richard Aplenc,E. Anders Kolb,Rhonda E. Ries,Todd A. Alonzo,Stanley B. Pounds,Jatinder K. Lamba
View Articletitled, SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
Supplemental data

PLATELETS AND THROMBOPOIESIS

Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis
Gagan D. Flora,Manasa K. Nayak,Madankumar Ghatge,Mariia Kumskova,Rakesh B. Patel,Anil K. Chauhan
View Articletitled, Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Oxygen saturation, brain white matte connectivity and processing speed in sickle cell disease

Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia
Jonathan D. Clayden,Hanne Stotesbury,Jamie M. Kawadler,April Slee,Melanie Kӧlbel,Dawn E. Saunders,Anna M. Hood,Olu Wilkey,Mark Layton,Baba Inusa,Maria Pelidis,Subarna Chakravorty,David C. Rees,Jo Howard,Moji Awogbade,Christina Liossi,Fenella J. Kirkham,Chris A. Clark
View Articletitled, Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia
Supplemental data
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting
Clinical Trials & Observations Global Advances
Lauren J. Klein,Shehu Umar Abdullahi,Safiya Gambo,Virginia A. Stallings,Sari Acra,Mark Rodeghier,Michael R. DeBaun
View Articletitled, Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting
Supplemental data

THROMBOSIS AND HEMOSTASIS

Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
Lukas J. Weiss,Maria Drayss,Georgi Manukjan,Maximilian Zeitlhöfler,Judith Kleiss,Mathis Weigel,Johannes Herrmann,Kristina Mott,Sarah Beck,Philipp Burkard,Thiên-Trí Lâm,Karina Althaus,Tamam Bakchoul,Stefan Frantz,Patrick Meybohm,Bernhard Nieswandt,Dirk Weismann,Harald Schulze
View Articletitled, Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
Supplemental data
Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer
Chantal Kroone,Chris Tieken,Begüm Kocatürk,Madelon Paauwe,Erik J. Blok,Betül Ünlü,Yascha W. van den Berg,Eliana Stanganello,Maaike Y. Kapteijn,Nathalie Swier,Xi Zhang,Danique E. M. Duits,Yazhi Lin,Lisa V. E. Oostenbrink,Rob F. P. van den Akker,Laurent O. Mosnier,Lukas J. Hawinkels,Bart J. M. van Vlijmen,Wolfram Ruf,Peter J. Kuppen,Suzanne C. Cannegieter,Jeroen T. Buijs,Henri H. Versteeg
View Articletitled, Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer
Supplemental data
Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation
Leonid A. Parunov,Yideng Liang,Qijin Lu,Alexey M. Shibeko,Erik I. Tucker,Timothy K. Lee,Fazoil I. Ataullakhanov,Dorothy E. Scott,Mikhail V. Ovanesov
View Articletitled, Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation
Supplemental data

TRANSFUSION MEDICINE

Clinical and epidemiological features of paroxysmal cold hemoglobinuria: a systematic review
Jeremy W. Jacobs,Cristina A. Figueroa Villalba,Garrett S. Booth,Jennifer S. Woo,Laura D. Stephens,Brian D. Adkins
View Articletitled, Clinical and epidemiological features of paroxysmal cold hemoglobinuria: a systematic review
Supplemental data

TRANSPLANTATION

Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
Mahasweta Gooptu,Haesook T. Kim,Eric Jacobsen,David C. Fisher,Ann LaCasce,Vincent T. Ho,Corey S. Cutler,John Koreth,Robert J. Soiffer,Joseph H. Antin,Nancy Berliner,Sarah Nikiforow
View Articletitled, Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
Supplemental data

RESEARCH LETTERS

SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells
Yannis Hara,Viktor T. Lemgart,Nis Halland,Kiana Mahdaviani,Jean-Antoine Ribeil,Samuel Lessard,Alexandra Hicks,David R. Light
View Articletitled, SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells
Supplemental data
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
Clinical Trials & Observations
Antoine N. Saliba,Scott H. Kaufmann,Eytan M. Stein,Prapti A. Patel,Maria R. Baer,Wendy Stock,Michael Deininger,William Blum,Gary J. Schiller,Rebecca L. Olin,Mark R. Litzow,Tara L. Lin,Brian J. Ball,Michael M. Boyiadzis,Elie Traer,Olatoyosi Odenike,Martha L. Arellano,Alison Walker,Vu H. Duong,Tibor Kovacsovics,Robert H. Collins,Abigail B. Shoben,Nyla A. Heerema,Matthew C. Foster,Kevin L. Peterson,Paula A. Schneider,Molly Martycz,Theophilus J. Gana,Leonard Rosenberg,Sonja Marcus,Ashley O. Yocum,Timothy Chen,Mona Stefanos,Alice S. Mims,Uma Borate,Amy Burd,Brian J. Druker,Ross L. Levine,John C. Byrd,James M. Foran
View Articletitled, Pevonedistat with azacitidine in older patients with <em>TP53</em>-mutated AML: a phase 2 study with laboratory correlates
Supplemental data
Under-representation of classical hematology training on hematology-oncology fellowship program websites in the United States
Puja Panwar,Jennifer M. Jones,Jana Christian,Jennifer C. Yui,Rakhi P. Naik
View Articletitled, Under-representation of classical hematology training on hematology-oncology fellowship program websites in the United States
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells
Clinical Trials & Observations
Katie Maurer,Haesook T. Kim,Heather M. Garrity,Deborah Liney,Corey Cutler,Joseph H. Antin,John Koreth,Jerome Ritz,Roman M. Shapiro,Rizwan Romee,Vincent T. Ho,Mahasweta Gooptu,Robert J. Soiffer,Catherine J. Wu,Sarah Nikiforow
View Articletitled, Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies
Clinical Trials & Observations
Andres Chang,Jean L. Koff,Lilin Lai,Victor M. Orellana-Noia,Minal Surati,Alyssa M. K. Leal,Madison L. Ellis,Bushra Wali,Alberto Moreno,Susanne L. Linderman,Colin B. O’Leary,Pamela B. Allen,Michael C. Churnetski,Madhav V. Dhodapkar,Mehul S. Suthar,Jonathon B. Cohen,Rafi Ahmed
View Articletitled, Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies
Supplemental data
Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy
Fateeha Furqan,Morgan Maring,Aniko Szabo,Timothy S. Fenske,Mehdi Hamadani,Nirav N. Shah
View Articletitled, Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy
Supplemental data
High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes
Yu-Hung Wang,Chien-Chin Lin,Chi-Yuan Yao,Fabio M. R. Amaral,Shan-Chi Yu,Chein-Jun Kao,Pin-Tsen Shih,Hsin-An Hou,Wen-Chien Chou,Hwei-Fang Tien
View Articletitled, High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes
Supplemental data
Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis
Clinical Trials & Observations
Parth Sharma,Annapurna Saksena,Adolfo Diaz,Yifan Pang,Parth Desai
View Articletitled, Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis
pH-dependent conformation of multimeric von Willebrand factor
Ian W. Smith,Ernest T. Parker,Pete Lollar
View Articletitled, pH-dependent conformation of multimeric von Willebrand factor
Genomics of PDGFR-rearranged hypereosinophilic syndrome
Esther Rheinbay,Meifang Qi,Juliette M. Bouyssou,Andrew J. Oler,Lauren Thumm,Michelle Makiya,Irina Maric,Amy D. Klion,Andrew A. Lane
View Articletitled, Genomics of PDGFR-rearranged hypereosinophilic syndrome
Supplemental data
Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019
Adam S. Kittai,Ying Huang,Seema A. Bhat,Electra D. Paskett,Kerry A. Rogers,Jacqueline C. Barrientos,James L. Fisher,Jennifer A. Woyach
View Articletitled, Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation
Harry J. Iland,Nigel Russell,Richard Dillon,Andre C. Schuh,Aditya Tedjaseputra,Andrew Wei,Asim Khwaja,Steven Knapper,Steven W. Lane,John Reynolds,Mary Frances McMullin,Annalise Martin,Peter Tan,David C. Taussig,Anny Wong,John Taper,Christina Fraga,Richard Kelly,Kiran Tawana,Priyanka Mehta,Alain Mina,Jessica K. Altman,Ingolf Mølle,Sudhir Tauro,Eleni Tholouli
View Articletitled, Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation
Supplemental data
ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
Paolo Strati,Oren Pasvolsky,Lei Feng,Guofan Xu,Sanjit O. Tewari,Jaimole Varghese,Karla Ow,Minifrida Santiago,Ajlan Al Zaki,Andrew Jallouk,Sattva S. Neelapu,Partow Kebriaei,Elizabeth J. Shpall,Sairah Ahmed
View Articletitled, ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia
Yagahira E. Castro-Sesquen,Santosh L. Saraf,Victor R. Gordeuk,Sergei Nekhai,Marina Jerebtsova
View Articletitled, Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia

COMMENTARIES

Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma
John Gribben,M. Lia Palomba,Anik R. Patel,Myrna Nahas,Sattva S. Neelapu
View Articletitled, Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma
Transfusion therapy for sickle cell disease: what’s new?
Stella T. Chou,Jeanne E. Hendrickson,Ross M. Fasano
View Articletitled, Transfusion therapy for sickle cell disease: what’s new?

RESPONSE

Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma
Kunal C. Potnis,Scott F. Huntington
View Articletitled, Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma

ERRATUM

Ay C, Pabinger I, Kovacevic KD, et al. The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease. Blood Adv. 2022;6(18):5467-5476.
View Articletitled, Ay C, Pabinger I, Kovacevic KD, et al. The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease. <em>Blood Adv.</em> 2022;6(18):5467-5476<em>.</em>
  • Cover Image

    Cover Image

    issue cover

    Top-down view of the brain, highlighting regions showing significant structural connectivity differences between a group of patients with sickle cell anemia and a control group. See the article by Clayden et al.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement

Sahin I, Kawano Y, Sklavenitis-Pistofidis R, et al. Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma. Blood Adv. 2019;3(7):995-1002.
Jian Y, Chang L, Shi M-X, et al. Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment. Blood Adv. 2023;7(24):7581-7584.
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1–positive BCP-ALL beyond kinase domain mutations
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement